Skip to main content
OpenTrials

Clinical trial condition

Neurofibromatoses

Explore clinical trials studying Neurofibromatoses. Study availability and eligibility vary by location and protocol.

143 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Neurofibromatoses trial results

Recruiting

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

NCT05849662

Conditions
Bone Marrow Diseases, CBL Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital of Colorado Denver, Colorado, United States
View all 21 locations
View Trial Details
Recruiting

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

NCT04374305

Conditions
Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, +38 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • University of Miami Miami, Florida, United States
  • Indiana University School of Medicine Indianopolis, Indiana, United States
  • Johns Hopkins Hospital Baltimore, Maryland, United States
View Trial Details
Recruiting

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

NCT02544022

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Chicago Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
View Trial Details
Recruiting

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

NCT06502171

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +17 more
Locations
  • Childrens of Alabama Birmingham, Alabama, United States
  • Children's National Hospital Washington D.C., District of Columbia, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
  • Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
View Trial Details

Related conditions